Tigecycline
Spezifikationen
220620-09-7CAS-Nummer
(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamideIUPAC-Name
C29H39N5O8Chemische Formel
585.6 g/molMolekulargewicht
Tigecycline; 220620-09-7; Tygacil; WAY-GAR-936; GAR-936; TBG-MINO; GAR 936; (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; DTXSID2048581; MFCD00935753; (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; 70JE2N95KR; CHEBI:149836; C29H39N5O8; (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; (4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; (4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tigecycline [USAN]; Tigilcycline; GAR-936,Tigecycline; Tygacil(TM); Tygacil (TN); tiglicycline; Tigeciclina; Tigecycline?; Tigecycline CRS; 9-t-Butylglycylamido minocycline; Haizheng Li Xing; Tigecycline 95%; NCGC00183095-01; (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline;; (4s,4as,5ar,12as)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; T1C; Tigecycline (Standard); Tigecycline (JAN/USP); TIGECYCLINE [MI]; TIGECYCLINE [INN]; TIGECYCLINE [JAN]; TIGECYCLINE [VANDF]; TIGECYCLINE [MART.]; UNII-70JE2N95KR; TIGECYCLINE [USP-RS]; TIGECYCLINE [WHO-DD]; (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1; MLS006010079; SCHEMBL101795; SCHEMBL105082; SCHEMBL237962; TIGECYCLINE [EMA EPAR]; Tigecycline [USAN:INN:BAN]; CHEMBL376140; GAR936; orb1308145; orb3141209; DTXCID8028507; SCHEMBL27246570; SCHEMBL29699251; SCHEMBL30423132; GTPL10929; HSDB 8172; HY-B0117R; MSK7046; TIGECYCLINE [ORANGE BOOK]; 9-tert-Butylglycylamidominocycline; HMS3714I13; TIGECYCLINE [EP MONOGRAPH]; TIGECYCLINE [USP MONOGRAPH]; HY-B0117; Tox21_112910; BDBM50247905; EBC-11312; NSC794945; s1403; AKOS015895663; AKOS025401452; AKOS037643695; Tigecycline for system suitability CRS; AC-1798; CCG-270150; CS-1876; DB00560; NSC-794945; Tigecycline(Discontinued,SeeC4X-1860); (4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide; 121GE002; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; AS-30703; SMR002530064; CAS-220620-09-7; NS00011897; D01079; AB01566818_01; EN300-19769236; Q420595; (4s,4as,5ar,12as)-9-(2-t-butylaminoacetylamino)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydronaphthacene-2-carboxamide; (4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-Synonyme
Produkte, die Tigecycline enthalten
타이가실주(타이제사이클린)펜믹스타이제사이클린주タイガシル点滴静注用50mgTIGECICLINA VIATRIS 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA TARBIS 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA NORIDEM 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA HIKMA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA CIPLA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTYGACIL 50 MG POLVO PARA SOLUCION PARA PERFUSIONTIGECICLINA TECNIGEN 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGTIGECICLINA NORMON 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG
Seite 1 von 5
Unternehmen, die Tigecycline verkaufen
HF
HIKMA FARMACEUTICAPortugalAH
ANFARM HELLAS S.A.GreeceGP
GLAND PHARMA LIMITEDIndiaHD
Hangzhou Dingyan Chem Co., LtdChinaNK
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.ChinaSP
STARWAY PHARM Co., Ltd.ChinaSeite 1 von 4